MedPath

Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers

Not Applicable
Completed
Conditions
Vision Disorders
Interventions
Device: SofLens59 contact lens
Device: PureVision Multi-Focal contact lenses
Registration Number
NCT00985231
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

This study is being conducted to evaluate Bausch \& Lomb PureVision Multi-Focal contact lenses compared to the Bausch \& Lomb SofLens59 contact lens when worn by adapted soft contact lens wearers on a daily wear basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
272
Inclusion Criteria
  • Subjects must have clear central corneas and be free of any anterior segment disorders.
  • Subjects must be adapted soft contact lens wearers and agree to wear the study lenses on a daily wear basis for at least eight hours a day for approximately two weeks.
  • Subjects must wear a lens in each eye and each lens must be of the same manufacture and brand.
Exclusion Criteria
  • Subjects participating in any drug or device clinical investigation within two weeks prior to entry into this study and/or during the period of study participation.
  • Subjects with any systemic disease affecting ocular health
  • Subjects with an active ocular disease or using any ocular medication.
  • Subjects who have had any corneal surgery (eg, refractive surgery).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SofLens59 contact lensSofLens59 contact lens-
PureVision Multi-Focal contact lensesPureVision Multi-Focal contact lenses-
Primary Outcome Measures
NameTimeMethod
Distance Visual Acuity (VA) Between Test and Control Lenses Worse Than 20/40.2 weeks

Eyes with distance lens VA of 20/40 or worse at study exit between test and control lenses.

Secondary Outcome Measures
NameTimeMethod
Subjective Ratings of Eye Strain2 week visit

Convergence Insufficiency Symptom Survey (CISS), was used to assess eye strain symptoms measured on a scale of 1-4. 0 score=never, 4 score=always

Trial Locations

Locations (1)

Bausch & Lomb

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath